Other Clinical Trial - Use of 3,4-Diaminopyridine in the Treatment of

See also
Status	Clinical Trial	Phase
Completed	`NCT01377922` - A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)	Phase 3
Active, not recruiting	`NCT00716066` - Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases	Phase 2
No longer available	`NCT00704925` - Treatment of Lambert-Eaton Syndrome With 3,4 DAP

See also

Status

Clinical Trial

Phase

Completed

NCT01377922 - A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)

Phase 3

Active, not recruiting

NCT00716066 - Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Phase 2

No longer available

NCT00704925 - Treatment of Lambert-Eaton Syndrome With 3,4 DAP

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01825395
Study type	Expanded Access
Source	University of Colorado, Denver
Contact
Status	Approved for marketing
Phase

Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome — 3 4-DAP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms